Patents by Inventor James Doyle

James Doyle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11984317
    Abstract: Techniques, structures, and materials related to extreme ultraviolet (EUV) lithography are discussed. Multiple patterning inclusive of first patterning a grating of parallel lines and second patterning utilizing EUV lithography to form plugs in the grating, and optional trimming of the plugs may be employed. EUV resists, surface treatments, resist additives, and optional processing inclusive of plug healing, angled etch processing, electric field enhanced post exposure bake are described, which provide improved processing reliability, feature definition, and critical dimensions.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: May 14, 2024
    Assignee: Intel Corporation
    Inventors: Marie Krysak, James Blackwell, Lauren Doyle, Brian Zaccheo, Patrick Theofanis, Michael Robinson, Florian Gstrein
  • Patent number: 11980369
    Abstract: A pulmonary artery flow restrictor system includes a funnel shaped membrane with a proximal base and a restrictive distal opening which is stretchable to larger sizes. A self-expanding frame is attached to the proximal base of the membrane for securing the membrane within the pulmonary artery.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: May 14, 2024
    Assignee: Vivonics, Inc.
    Inventors: James H. Goldie, Brendan LaBrecque, Anna M Galea, Eric Klem, Thomas Doyle, Ian Cohen, Tim Robinson
  • Patent number: 11975175
    Abstract: Methods and systems are provided for determining fluid administration. The system may determine fluid administration based on the fluid responsiveness and regional oxygen saturation of a subject. The system may receive the fluid responsiveness and regional oxygen saturation from external sources or may determine one or both based on received physiological signals. In some embodiments, the system may determine whether to administer fluid based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the amount of fluid to administer based on the fluid responsiveness and regional oxygen saturation. In some embodiments, the system may determine the effectiveness of fluid administration. In some embodiments, the system may provide an indication of the determined fluid administration so that a care-giver can implement the appropriate fluid administration. In some embodiments, the system may control the fluid administration based on its determination.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: May 7, 2024
    Assignee: COVIDIEN LP
    Inventors: Peter Doyle, Paul S. Addison, James N. Watson
  • Publication number: 20240141053
    Abstract: The disclosure provides TNF-like ligand 1a (TL1a)-binding proteins comprising an antigen binding domain of an antibody which binds specifically to TL1a and inhibits interaction of TL1a and Death Receptor 3 (DR3) and which does not inhibit the interaction of TL1a and Decoy Receptor 3 (DcR3). The disclosure also provides uses of the TL1a-binding proteins.
    Type: Application
    Filed: April 20, 2023
    Publication date: May 2, 2024
    Inventors: Lynn Dorothy POULTON, Adam CLARKE, Andrew James POW, Debra TAMVAKIS, George KOPSIDAS, Anthony Gerard DOYLE, Philip Anthony JENNINGS, Matthew POLLARD
  • Publication number: 20240141994
    Abstract: An orientation agnostic ring seal includes an annular body defining an axial hole therethrough for fluid passage in an axial direction and having a radial plane that is perpendicular to the axial direction. Both axial sides of the ring seal include a deformable annular protrusion extending from the annular body in an axial direction to a first apex, which is configured to deform upon engagement with a first planar sealing surface, and a first seal ring engagement surface configured to engage a first annular rounded sealing ring. So configured, the ring seal can seal two different types of flow components regardless of its orientation.
    Type: Application
    Filed: February 17, 2022
    Publication date: May 2, 2024
    Inventors: Gregory Doyle, Puntaruk Hirunyanont, James William Martin
  • Publication number: 20240132455
    Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: December 8, 2023
    Publication date: April 25, 2024
    Inventors: Hans Roland LÖNN, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof PONTÉN, Kevin James Doyle, Amanda Jane VAN DE POËL, Graham Peter Jones, David Wyn Watson, Jacqueline Anne MACRITCHIE, Nicholas John Palmer
  • Publication number: 20240134400
    Abstract: An appliance hub for use in an upper portion of an enclosure can include a substrate configured to be positioned in an upper portion of an enclosure. The appliance hub can include a climate control apparatus mounted on the substrate and the climate control apparatus can be configured to regulate a temperature within the enclosure. The appliance hub can include one or more lighting elements configured to provide light within the enclosure, a plurality of fluid lines connected to the substrate and configured to provide fluid service and return to the climate control apparatus, and/or a plurality of electrical connections connected to the substrate and configured to provide electrical power and/or data to at least one of the climate control apparatus and the one or more lighting elements.
    Type: Application
    Filed: December 6, 2023
    Publication date: April 25, 2024
    Inventors: Dean C. Allen, Douglas James Moore, Andrea M. Doyle, Larry Paul Highley
  • Publication number: 20240098882
    Abstract: An electronic component includes a first trace configured to transmit a first signal and a second trace configured to transmit a second signal. The electronic component further includes a layer of conductive material separated from the first and second traces by a layer of insulative material. The electronic component further includes a first vertical wall formed in direct contact with the layer of conductive material. The electronic component further includes a second vertical wall formed in direct contact with the layer of conductive material. The second vertical wall is separated from the first vertical wall by a void, and the void extends between the first trace and the second trace.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 21, 2024
    Inventors: Matthew Doyle, DAVID CLIFFORD LONG, Matteo Cocchini, Russell A. Budd, James Busby, Roger S. Krabbenhoft, Arthur J. Higby
  • Publication number: 20240087527
    Abstract: An electronic device may have a display mounted in a housing. The display may have a pixel array that produces images. A display cover layer may overlap the pixel array. The display cover layer may have a planar central area surrounded by a peripheral edge area with a curved cross-sectional profile. From an on-axis viewing angle, an image on the pixel array is fully viewable through the planar central area and the peripheral edge area. From an off-axis viewing angle, the image is partly viewable through the peripheral edge area and not through the central area. To avoid an undesired color cast in the partly viewable image seen through the peripheral edge area of the display cover layer, the display may be provided with color cast compensation structures such as a guest-host liquid crystal layer that exhibits an anisotropic colored light absorption characteristic, a diffuser layer, and/or other optical structures.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Inventors: Sameer Pandya, Daniel J. Barrett, Erik G. de Jong, James P. Landry, David A. Doyle, Jean-Pierre S. Guillou, Jung Yun Seuh, Yi Qiao
  • Patent number: 11923722
    Abstract: Disclosed are systems and methods to provide continuous power to electrical devices using a portable power supply unit and a portable power charging unit. The portable power supply unit may include a first battery providing a first DC output, at least one first inverter for converting said first DC output to a first AC output for powering the electrical devices and for converting a first AC input to a first DC input for charging said first battery The portable power charging unit may include a second battery for providing a second DC output, a second inverter for converting said second DC output to a second AC output; and transmitting the second AC output to the first battery using charging ports on respective units such that said second AC output replaces said first AC output for powering said electrical devices, and replaces said first AC input for charging said first battery.
    Type: Grant
    Filed: October 7, 2021
    Date of Patent: March 5, 2024
    Inventor: James Doyle Schwalm, Jr.
  • Publication number: 20240070168
    Abstract: An example method for offline data synchronization to generate a representation of a space includes: localizing a data capture device in the space; detecting, by the data capture device, a nearby additional data capture device; in response to detecting the additional data capture device, establishing a communications channel to the additional data capture device; generating data representing the space; generating synchronization data based on the generated data; and sending the synchronization data to the additional capture device via the communications channel.
    Type: Application
    Filed: August 18, 2023
    Publication date: February 29, 2024
    Inventors: Dae Hyun Lee, Tyler James Doyle
  • Patent number: 11908668
    Abstract: An apparatus for obtaining ion energy distribution, IED, measurements in a plasma processing system, in one example, comprising a substrate for placement in the plasma processing system and exposed to the plasma, an ion energy analyser disposed in the substrate for measuring the ion energy distribution at the substrate surface during plasma processing, the analyser comprising a first conductive grid, a second conductive grid, a third conductive grid, a fourth conductive grid, and a collection electrode, each grid separated by an insulation layer, a battery power supply and control circuitry, integrated in the substrate, for supplying and controlling voltage to each of the grids and the collector of the ion energy analyser; wherein at least one insulation layer includes a peripheral portion which is of reduced thickness with respect to the remaining portion of the insulation layer.
    Type: Grant
    Filed: September 6, 2021
    Date of Patent: February 20, 2024
    Assignee: IMPEDANS LTD
    Inventors: Paul Scullin, James Doyle, JJ Lennon, David Gahan, Tigran Poghosyan
  • Publication number: 20230416355
    Abstract: Described herein are anti-IL-8 antibodies, compositions thereof, and methods of use thereof. The anti-IL-8 antibodies N would be useful in methods of inhibiting tumor formation or growth or a combination thereof. Described herein are also methods of using the anti-IL-8 antibodies for methods of treating a disease, wherein diseases may include cancer, a tumor, or a viral infection.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 28, 2023
    Applicant: STELEXIS THERAPEUTICS, LLC
    Inventors: Keren Paz, Nicole Covino, Yasumi Nakayama, Patrick James Doyle, Carmine Carpenito, Lynn Biderman, Bozena Bugaj-Gaweda, John Andrew Lippincott, Dana Yen Mei Duey
  • Publication number: 20230388461
    Abstract: A system and method for altering the visual appearance of moving physical forms is disclosed. The moving physical forms may include solids, liquids, gasses and any combination thereof. The system and method may include video capturing devices for capturing video footage of the moving forms, a controller for altering the captured video footage of the moving forms, and video projecting devices for projecting the altered video footage back onto the moving forms.
    Type: Application
    Filed: May 2, 2023
    Publication date: November 30, 2023
    Applicant: WET
    Inventors: Mark Fuller, James Doyle, Gautam Rangan, Scott Winslow, Isaiah Gernhardt, Ting Zhang
  • Patent number: 11814359
    Abstract: The present disclosure relates to certain (2,S)-N-[(1,S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: September 10, 2022
    Date of Patent: November 14, 2023
    Assignee: AstraZeneca AB
    Inventors: Hans Roland Lönn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jacqueline Anne Macritchie, Nicholas John Palmer
  • Patent number: 11813629
    Abstract: A water display including a number of pixels or manifolds that may include water nozzles to emit streams of water and/or other utilities such as lighting is described. The water streams may be pixelated so as to provide a high resolution waveform or other choreography. The choreography transitions between waveforms to provide the appearance of a cascading or undulating wave. A tool to design the water display and simulate its appearance is also described.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: November 14, 2023
    Assignee: WET
    Inventors: Mark Fuller, James Doyle, Markos Okihisa, Gautam Rangan
  • Publication number: 20230326078
    Abstract: There is provided a system and method of re-projecting and combining sensor data of a scene from a plurality of sensors for visualization. The method including: receiving the sensor data from the plurality of sensors; re-projecting the sensor data from each of the sensors into a new viewpoint; localizing each of the re-projected sensor data; combining the localized re-projected sensor data into a combined image; and outputting the combined image. In a particular case, the receiving and re-projecting can be performed locally at each of the sensors.
    Type: Application
    Filed: June 13, 2023
    Publication date: October 12, 2023
    Inventors: Dae Hyun Lee, Tyler James Doyle
  • Patent number: 11773069
    Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: October 3, 2023
    Assignee: AstraZeneca AB
    Inventors: Hans Roland Lönn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
  • Publication number: 20230278969
    Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: September 9, 2022
    Publication date: September 7, 2023
    Inventors: Hans Roland LÖNN, Stephen CONNOLLY, Steven SWALLOW, Staffan PO KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER
  • Publication number: 20230250071
    Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.
    Type: Application
    Filed: April 13, 2023
    Publication date: August 10, 2023
    Inventors: Hans Roland LÖNN, Stephen CONNOLLY, Steven SWALLOW, Staffan Po KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER